These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33124569)

  • 21. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
    De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
    Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA; Tournadre A
    Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MyomiRs in cultured muscle cells from patients with idiopathic inflammatory myopathy are modulated by disease but not by 6-month exercise training.
    Alchus Laiferová N; Nemec M; Vernerová L; Balážová M; Vokurková M; Oreská S; Klein M; Špiritović M; Tomčík M; Vencovský J; Ukropec J; Ukropcová B
    Clin Exp Rheumatol; 2022 Feb; 40(2):346-357. PubMed ID: 35225219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health-related quality of life and work impairment in idiopathic inflammatory myopathies in South Australia.
    Xu A; Sun C; Metcalf R; Limaye V
    Int J Rheum Dis; 2021 Jun; 24(6):809-814. PubMed ID: 33881230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease.
    Pucci S; Greggi C; Polidoro C; Piro MC; Celi M; Feola M; Gasbarra E; Iundusi R; Mastrangeli F; Novelli G; Orlandi A; Tarantino U
    J Transl Med; 2019 Apr; 17(1):118. PubMed ID: 30967152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
    Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
    Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.
    Galindo-Feria AS; Lodin K; Horuluoglu B; Sarrafzadeh-Zargar S; Wigren E; Gräslund S; Danielsson O; Wahren-Herlenius M; Dastmalchi M; Lundberg IE;
    Rheumatology (Oxford); 2024 Jun; ():. PubMed ID: 38833674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of body composition and alteration after treatment in patients with newly diagnosed idiopathic inflammatory myopathies.
    Yang S; Luo C; Zheng W; Li X; Zhang X; Jiang Y; Xiao F
    Rheumatology (Oxford); 2022 Dec; 62(1):270-280. PubMed ID: 35552653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR-based serum and muscle metabolomics for diagnosis and activity assessment in idiopathic inflammatory myopathies.
    Guleria A; Kumar U; Kumar D; R N; Anuja AK; Singh MK; Sharma P; Agarwal V; Misra R; Gupta L
    Anal Sci Adv; 2021 Dec; 2(11-12):515-526. PubMed ID: 38715864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.
    Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D
    Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant expansion of circulating CD4
    Zhang L; Li W; Cai Y; Liu X; Peng Q; Liang L
    Int J Rheum Dis; 2020 Mar; 23(3):397-405. PubMed ID: 31883219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
    Day JA; Bajic N; Gentili S; Patel S; Limaye V
    Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Statin Exposure With Histologically Confirmed Idiopathic Inflammatory Myositis in an Australian Population.
    Caughey GE; Gabb GM; Ronson S; Ward M; Beukelman T; Hill CL; Limaye V
    JAMA Intern Med; 2018 Sep; 178(9):1224-1229. PubMed ID: 30073275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness?
    Lightfoot AP; McArdle A; Jackson MJ; Cooper RG
    Ann Rheum Dis; 2015 Jul; 74(7):1340-6. PubMed ID: 26063809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training.
    Nemec M; Vernerová L; Laiferová N; Balážová M; Vokurková M; Kurdiová T; Oreská S; Kubínová K; Klein M; Špiritović M; Tomčík M; Vencovský J; Ukropec J; Ukropcová B
    J Physiol; 2021 Jan; 599(1):207-229. PubMed ID: 33063873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies.
    Mageriu V; Manole E; Bastian AE; Staniceanu F
    J Immunol Res; 2020; 2020():9079083. PubMed ID: 32775472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis.
    De Paepe B; Verhamme F; De Bleecker JL
    Cytokine; 2020 Mar; 127():154966. PubMed ID: 31901761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of urinary N-terminal fragment of titin for skeletal muscle damage in idiopathic inflammatory myopathy.
    Sun J; Ye S; Yin G; Xie Q
    Rheumatology (Oxford); 2023 Nov; 62(11):3742-3748. PubMed ID: 36919777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel autoantibody against heat shock factor 1 in idiopathic inflammatory myopathy.
    Zhang YM; Liang L; Yang HB; Shu XM; Lu X; Wang GC; Peng QL
    Clin Exp Rheumatol; 2020; 38(6):1191-1200. PubMed ID: 32141435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The expression of tumor necrosis factor-related apoptosis inducing ligand and its receptors in muscle tissue of inflammatory myopathies].
    Zhao H; Wang GC
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):369-73. PubMed ID: 18953943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.